Leprosy is a complex infectious disease influenced by genetic and environmental factors. The genetic contributing factors are considered heterogeneous and several genes have been consistently associated with susceptibility like PARK2, tumor necrosis factor (TNF), lymphotoxin-a (LTA) and vitamin-D receptor (VDR). Here, we combined a case-control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy. We observed that the À819T allele is associated with leprosy susceptibility either in the case-control or in the meta-analysis studies. Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the À819T allele in leprosy susceptibility (odds ratio (OR) ¼ 1.40; P ¼ 0.01). Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that À819T carriers produced lower levels of IL-10 when compared with noncarriers. Taken together, these data suggest that low levels of IL-10 during the disease outcome can drive patients to a chronic and unprotective response that culminates with leprosy.
Introduction
Leprosy is a chronic disease caused by Mycobacterium leprae that infects macrophages in skin and Schwann cells in nerves. The global number of new cases is still high; around 260 000 patients registered in 2006, and it is estimated that one-third of these patients exhibit a form of nerve injury that leads to disabilities. 1 Epidemiological and clinical observations suggested that the disease does not occur in most of the exposed individuals, and only 0.1-1% develop leprosy. 2 Thus, the vast majority of people have some sort of innate resistance that can be, at least in part, explained by their genetic background. There is a large body of evidence indicating genetic influence in leprosy outcome, such as (i) familial clustering; (ii) distinct prevalence rates associated with distinct ethnic groups in an endemic area with similar exposure to the infectious agent; (iii) in complex segregation analyses, candidate gene approaches and genome-wide scans various genetic associations and linkages have been demonstrated. 3, 4 Furthermore, high-throughput sequencing data from M. leprae genomes suggest that this pathogen has a very low genetic diversity, 5 indicating a crucial role for the host genetics in disease outcome. Thus, leprosy has been considered a model for genetic susceptibility studies. 4 However, results on genetic screenings and case-control designs on candidate genes are still controversial and any region, gene or single-nucleotide polymorphism (SNP), unequivocally associated with leprosy is rarely reported. 4 Among these, PARK2/PACRG, TNF/LTA/HLADRB1, VDR and IL10 have been analyzed in more than one population in studies demonstrating the association of these genes with disease. 3, 6, 7 Interleukin (IL)-10 is an immunoregulatory cytokine that is primarily secreted by cells of the monocyte/macrophage lineage. 8 CD4 þ T-regulatory 1 cells secreting IL-10 have been characterized mediating suppression of T-helper cells, 9 and these Tr1 cells are critical in controlling pathogen-driven response. IL-10 downregulates T-helper 1 cytokines and costimulatory molecules on macrophages, contributing to the persistence of the pathogens. 10 Moreover, IL10 is localized in 1q32, a region where other important immunoregulatory cytokines are clustered (IL-19, IL-20 and IL-24) and have been associated with other skin diseases like psoriasis and systemic lupus erythematosus. 11, 12 Genetic epidemiological studies evaluated leprosy in Brazilian, Indian and Malawian populations. 3 In the Brazilian population, two different studies demonstrated the association of IL10 loci with leprosy. Santos et al. 13 showed that À819T allele was associated with leprosy susceptibility. Later, extended haplotypes were studied and the combination of À3575A/À2849G/À2763C/ À1082G/À819C was associated with resistance, whereas À3575T/À2849A/À2763C/À1082G/À819T was the susceptible haplotype 14 confirming the participation of À819T as a susceptibility allele of the locus. A replication study carried out in Indians implicated a different promoter haplotype associated with leprosy susceptibility (À3575T/À2849G/À2763C/À1082A/À819T/À592A), but again À819T was associated with the disease outcome. 15 Finally, in a study among a Malawi population, proximal IL10 SNPs were not associated with leprosy. 16 In this study, we replicated the data of the IL10 promoter SNPs using a case-control design in a countryside Brazilian population from the state of São Paulo. We analyzed pooled published data using meta-analysis to clear ambiguity among papers published using À819C/T and, finally, this SNP was also a marker for in vitro genetic influence of IL-10 production.
Results

IL10 genotyping
All SNP frequencies were in Hardy-Weinberg equilibrium (HWE) in control and leprosy patient groups, except À1082G/A in control group (P ¼ 0.002) and therefore this SNP was excluded from genotypic and haplotypic comparisons.
We performed pairwise linkage disequilibrium analysis using genotypes obtained from the control group. The D 0 values were at least 0.7 ( Supplementary Figure 1) , reflecting that there is an important association between these SNPs. Nevertheless, the r 2 values showed a low correlation between the markers (Supplementary Figure  1) , and according to the r 2 40.8 threshold defined by the HapMap project, 17 we could not define a tag to predict haplotype bins and all SNPs were compared between cases and controls ( Table 1) . Our results show that À819CT and À819TT genotypes as well as T-allele carriers were associated with leprosy susceptibility, whereas correction for covariates turned some comparisons borderline significant. No association between distal SNPs and disease outcome was observed.
The frequencies of haplotypes encompassing the four SNPs validated in this study at the IL10 promoter region were estimated (Table 2) . We collapsed all rare haplotypes (frequencies o0.03) in one group to avoid spurious associations. A high-frequency haplotype (0.30 for controls and 0.35 for patients) carrying the allele À819T (À3575T/À2849G/À2763C/À819T) was also associated with leprosy susceptibility (adjusted odds ratio (OR) ¼ 1.35; 95% confidence interval (CI) ¼ 1.03-1.78; P ¼ 0.03).
Meta-analysis
A total of four case-control studies were searched in the PubMed, all of them fitted the inclusion criteria and were combined with the present data to generate À819C/T meta-analysis (Supplementary Table 1 ). The modified Egger's test for funnel plot symmetry did not show significant evidence for publication bias (data not shown).
Results of meta-analysis are shown in Table 3 and Figure 1 . We found significant associations of the À819 SNP with leprosy susceptibility, with Table 2 and Supplementary Figure 2 ).
IL-10 measurement in PBMC culture supernatants
To evaluate the biological significance of À819C/T SNP genotypes and IL-10 production, peripheral blood mononuclear cell (PBMC) cultures were stimulated with different antigens and mitogens ( Figure 2 ). Individuals with the À819CC genotype produced higher amounts of IL-10 under any stimulus than À819T allele carriers (À819TT/TC genotypes). Statistically significant higher levels of IL-10 were observed among CC vs CT/TT carriers either when eight bacilli per ml was used as stimulus (median: 1293.8 vs 521.9 pg ml
À1
; P ¼ 0.019) or in non-stimulated cultures (median: 841.2 vs 550.7 pg ml
; P ¼ 0.047). Following lipopolysaccharide, phytohemagglutinin-M or sonicated M. leprae stimulation, no significant differences were observed between À819CC individuals when compared with À819TT/CT carriers.
Discussion
Here, we explored the effect of IL10 locus on leprosy susceptibility using genetic, epidemiological and immunological tools. To do so, we analyzed a predominantly Caucasoid population from countryside Southern Brazil in a case-control study. Both genotypes and haplotypes including the À819T allele were associated with leprosy susceptibility, confirming the earlier findings 13, 15 and suggesting this SNP as a marker for the locus. The study by Malhotra 15 found the most frequent haplotype associated with susceptibility and it was the same as that we observed here (exception for the presence of À1082G/A that we excluded from the comparison). In fact, the data that also combine the À1082G/A SNP to form haplotypes reinforced the results, demonstrating the combination carrying À819T as associated with leprosy susceptibility (data not shown).
The association exhibited an OR of approximately 1.4, suggesting a consistent risk of 40% for this allele in leprosy susceptibility. This result was reinforced with meta-analysis, in which the SNP À819C/T was tested in association with leprosy. [13] [14] [15] [16] The pooled sample reached a total of 2702 individuals (1355 cases and 1347 controls), including subjects belonging to three Brazilian, one Malawian and one Indian populations (total of five populations). We pooled data from papers found in the literature using key words, but also included our data that were not selected in a canonical way to compare with all selected papers for meta-analysis, but the results with or without our case-control study show basically the same: association of À819T with leprosy susceptibility. We adopted the random effects model despite the lack of heterogeneity evidence in Cochran's Q statistic because this test is underpowered when there are few studies under analysis. 18 The pooled ORs indicated that this SNP is indeed associated with leprosy and À819T (the minor frequent allele) was found to confer a susceptibility status in all combinations tested: T allele, T carriers and TT genotype. Exclusion of our new data from the meta-analysis decreased the pooled sample size to 1966 individuals (992 cases and 974 controls). The effect estimates remained almost unaltered but statistical power was clearly damaged. Consequently, T-carrier comparisons could not reach statistical significance, even though the point estimate was hardly altered. We also considered the use of À1082G/A in meta-analysis, but most of the published papers had genotypic data deviating from HWE, which led to the exclusion of these particular studies from the A
Finally, the phenotypic data suggest that this SNP indeed regulates the secretion of IL-10 in vitro. As expected, IL-10 production was not influenced by genotypes in every stimulus used. 19 Levels of IL-10 in PBMC cultures stimulated lipopolysaccharide, and phytohemagglutinin-M did not vary among À819C/T genotypes. Nevertheless, when M. leprae was used at eight bacilli per cell, significant differences between À819CC vs À819TT/CT carriers were observed. Also, without stimulation, the IL-10 innate response was also affected by each genotype. Surprisingly, either innate responses or M. leprae-stimulated À819TT/CT individuals produced lower levels of IL-10 as compared with À819CC individuals. This was unexpected as higher IL-10 levels are observed in patients exhibiting extreme forms (lepromatous) as compared with localized (tuberculoid) forms of leprosy. 20 Furthermore, IL10 is a major immunomodulator, being produced by T-regulatory cells, leading to anergy in tuberculosis, 21 while it also downregulates T-helper 1 responses and consequently protective immune responses. Thus, it is likely that different stimuli mobilize different transcription factors in a way that M. leprae, but not lipopolysaccharide or phytohemagglutinin-M, genetic regulates IL-10 levels through À819 promoter SNP. Family and twin studies showed that IL-10 production is, at least, 50% influenced by genetic factors. 22, 23 Moreover, À819C/T and À592C/A SNPs are in linkage disequilibrium 24 and have been considered as strong candidates for a regulatory role of the cytokine production as they are located in positive and negative regulatory elements, respectively, and the latter is inside a putative STAT3-binding site. 25 It has been reported that a lower production of IL-10 from À819T carriers in which the exchange of this nucleotide alters the binding affinity of nuclear transcription factors and À819T is also involved in leishmaniasis outcome. 26 In this functional analysis, we tested healthy people from an endemic area, which means that these people will respond to M. leprae, but similarly to the interaction during the early phases of the disease. We chose to do so because patients with high loads, like 10 10 mycobacteria, would obviously have biased levels of IL-10 production as they already produce the highest levels of IL-10. Even though we used healthy volunteers, we cannot guarantee that this pattern of IL-10 production would be followed in leprosy-susceptible individuals, but low and constant production of IL-10 has been reported to be crucial for chronification of leishmaniasis lesions. 27 Thus, À819T Abbreviations: CI, confidence interval; IL-10, interleukin-10; OR, odds ratio. Results are shown for random effects models. carriers as low IL-10 producers bring up a new understanding for the disease, where, maybe, these sustained low levels of IL-10 are necessary to lead leprosy to a chronic and unresponsive state. Leprosy and tuberculosis are diseases caused by similar intracellular pathogens. Recently, we showed that IFNG þ 874T/A was an important SNP in tuberculosis susceptibility, whereas IL-10 À1082G/A was not, 28 assuming that IL-10 locus is not contributing effectively to the outcome of tuberculosis. On the other hand, it seems that in leprosy, IL-10 SNPs are responsible for genetic effects controlling IL-10 production through a subtle but consistent association with leprosy susceptibility. So, it seems that different host immune strategies have evolved during interactions with intracellular pathogens, in which IL-10 is important for leprosy, but not for TB susceptibility.
Considering that leprosy is a chronic inflammatory disease and that severity is related to the host immune response, not only the amount, but also the timing of IL-10 production can be crucial to define disease outcome. In conclusion, our data point out the definitive role of the À819T allele in leprosy susceptibility and suggest that this polymorphism has a participation in a lower IL-10 production.
Materials and methods
Subjects
Case-control study. Seven-hundred and sixty individuals (374 cases and 380 controls) were selected from an outpatient unit at Lauro de Souza Lima Institute, Bauru, São Paulo State, located at the southeastern region of Brazil. The leprosy patients were classified in accordance with Ridley and Jopling 29 criteria and divided into multibacillary (n ¼ 291) and paucibacillary (n ¼ 79) as guided by the World Health Organization (WHO) for treatment purposes. The remaining four patients could not be classified as multibacillary or paucibacillary. Among patients, the mean age was 40.7 ± 17.5 years and the M/F gender ratio was 1.4. The healthy population (mean age ¼ 35.9 ± 10.7) was selected among blood donors from the same geographic area. In this control group, the M/F gender ratio was 1.95. Ethnicity was classified after careful inspection of facial morphological features, hair type, skin color and inquiry about direct ancestry until grandparents. Three groups were ascertained: caucasoids, mestizoes and blacks. Even though considering that common ethnicity markers do not cluster 'African-', 'Native' or 'Euro-Brazilians' as defined by morphological criteria, 30, 31 all comparisons were performed with both adjusting and not adjusting OR and P-values for ethnicity.
Taking the À819 SNP as an example, given the frequencies we found in our population, the power to detect an OR of 1.4 was about 62% when À819TT was compared with the other two genotypes. Nevertheless, we would have about 80% power to detect an OR as low as 1.5 for the other SNPs, given this same frequency distribution, which seems pretty reasonable.
Genotype-phenotype comparisons.
To analyze IL-10 production in vitro, 27 healthy volunteers were selected in accordance with their À819C/T genotype. A total of nine individuals exhibited À819CC genotype, five women and four men (mean age 41.1±10.4 years). Then, 18 À819T carriers (8 women and 10 men, mean age 42.7±13.3 years) were also selected. The study was approved by the ethical committee at Lauro de Souza Lima Institute and signed informed consent was obtained from all participants.
Genotyping
Genomic DNA was obtained from white blood cells by using the salting out method. Genotyping for the polymorphisms À819C/T, À1082G/A, À2763C/A, À2849G/A and À3575T/A in IL-10 promoter was performed by PCR restriction fragment length polymorphism.
PCR amplifications were carried out as described 14 with modifications. Briefly, PCR mix was carried out with 50 ng of genomic DNA, 10 pmol of each specific primer, 0.5 U of Taq DNA polymerase (Invitrogen, São Paulo, SP, Brazil), 0.2 mM of each dNTP (Invitrogen, Carlsbad, CA, USA) and 1.5 mM of MgCl 2 in a final reaction volume of 12.5 ml using a thermal cycler (MJ Research PTC100, Hercules, CA, USA). SNP typing at positions À2849 and À2763 was performed by nested PCR. 14 PCR products were digested by specific restriction enzymes (New England Biolabs, Beverly, MA, USA) for each SNP and genotypic profiles were determined by 2.0% agarose gel electrophoresis.
Peripheral blood mononuclear cell culture and IL-10 measurement Peripheral blood mononuclear cells were isolated from fresh blood of different donors using Ficoll-Hypaque (Sigma, St Louis, MO, USA) density centrifugation. The mononuclear cells were grown at 2 Â 10 5 cells per well in RPMI-1640 medium with L-glutamine, supplemented with 100 mg ml À1 of penicillin-streptomycin and 10% fetal bovine serum (Gibco, Grand Island, NY, USA). Cell cultures were stimulated for 48 h with 8 mg ml À1 of phytohemagglutinin-M (Sigma), 10 mg ml À1 of Escherichia coli lipopolysaccharide from Sigma, 10 mg ml À1 of irradiated and sonicated M. leprae (AgSon) and whole- irradiated M. leprae (kindly provided by Dr Patrick Brennan, Colorado State University, Fort Collins, CO, USA) at two and eight bacilli per cell. Cultures were incubated at 37 1C in a humidified 5% CO 2 atmosphere. The culture supernatants were harvested after 48 h and kept at À80 1C.
IL-10 levels were measured in cell-free supernatants in duplicate by enzyme-linked immunosorbent assay (IL-10 DuoSet; R&D Systems, Emeryville, CA, USA) according to the manufacturer's instructions. The lower limit of detection was 15.6 pg ml
À1
.
Identification of eligible studies and data extraction for meta-analysis We searched for studies that examined the association of IL10 À819C/T with leprosy. Literature search was made in MEDLINE using PubMed citations to identify available articles (from December 2002 to June 2008) in which the IL10 À819C/T SNP was tested for association with leprosy in case-control studies. Articles related to the selected papers (using PubMED search) and references in the studies were also reviewed to identify other studies. Keywords used were 'interleukin-10', 'IL-10', 'polymorphism', 'SNP' and 'leprosy', entered as text words. No language restrictions were applied. A study was included in the analysis if (1) it was published before June 2008, (2) it was not related to earlier publications and (3) it provided enough genetic data to calculate OR. We excluded studies (1) that contained overlapping data and (2) studies in which the control population deviated from HWE.
Statistical analysis
Case-control study. Deviations from HWE were tested with w 2 -tests. Genotype data were analyzed using genotypic and allelic frequencies by using logistic regression models adjusted for the covariates gender and ethnicity. Linkage disequilibrium was measured by D 0 and r 2 statistics.
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Haplotype frequencies were estimated by using the Expectation/Maximization algorithm. All analyses were performed using the statistical software R for Windows version 2.6.1, with the packages 'genetics' and 'haplo.stats'.
Meta-analysis. All analyses were performed as described. 28 Briefly, allele frequencies at the IL10 À819C/ T SNP from the selected studies were determined by the allele-counting method, and a w 2 -test was used to determine if observed frequencies of genotypes conformed to HWE. All comparisons were made with respect to the minor frequency allele. ORs were used as the point estimates of risk and were calculated along with their 95% CIs for each study. To test for publication bias, a modification of Egger's test was performed to provide statistical evidence for funnel plot symmetry. Heterogeneity across studies was assessed through Cochran's Q statistic and I 2 statistic. Finally, the overall or pooled estimate of risk (OR) was obtained by using Mantel-Haenszel method in the fixed-effect model and by using DerSimonian and Laird method in the random effects model. Pooled OR in the meta-analysis was performed weighting individual OR by the inverse of their variance. All analyses were carried out with R for Windows 2.6.1 with the package 'meta'.
Genotype-phenotype comparisons. Cytokine measurement data were analyzed by using non-parametric MannWhitney U-tests with GraphPad Instat version 3.00 for Windows (GraphPad Software, San Diego, CA, USA).
